G855-0129 Screening compound: 1-[6-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}sulfonyl)-1,2,3,4-tetrahydroquinolin-1-yl]ethan-1-one

G855-0129 Screening compound: 1-[6-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}sulfonyl)-1,2,3,4-tetrahydroquinolin-1-yl]ethan-1-one
G855-0129 Screening compound: 1-[6-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}sulfonyl)-1,2,3,4-tetrahydroquinolin-1-yl]ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G855-0129
1-[6-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}sulfonyl)-1,2,3,4-tetrahydroquinolin-1-yl]ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G855-0129

Molecular Formula

C22H24F3N3O3S (C22 H24 F3 N3 O3 S)

Compound Name

1-[6-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}sulfonyl)-1,2,3,4-tetrahydroquinolin-1-yl]ethan-1-one

IUPAC name

1-[6-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}sulfonyl)-1234-tetrahydroquinolin-1-yl]ethan-1-one

SMILES

CC(N(CCC1)c(cc2)c1cc2S(N(CC1)CCN1c1cc(C(F)(F)F)ccc1)(=O)=O)=O

InChI

InChI=1S/C22H24F3N3O3S/c1-16(29)28-9-3-4-17-14-20(7-8-21(17)28)32(30,31)27-12-10-26(11-13-27)19-6-2-5-18(15-19)22(23,24)25/h2,5-8,14-15H,3-4,9-13H2,1H3

InChI Key

JNJQRYCGWFPJEK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15040968

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.531

Distribution Coefficient, logD

3.531

Water Solubility, LogSw

-4.03

Polar Surface Area

51.262

Acid Dissociation Constant (pKa)

23.05

Base Dissociation Constant (pKb)

5.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

G855-0129 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with G855-0129 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G855-0129?
Check Price and Availability of G855-0129, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G855-0129 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G855-0129
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G855-0129
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G855-0129 available by request